glp 1 news The GLP-1 revolution: What UAB researchers are discovering about how these drugs work Common GLP-1 mistakes to avoid,

Compounding the problem is the fact that insurance companies are reluctant to cover these anti-obesity medications, since theyre considered by many to be vanity drugs, even though overwhelming evidence suggests obesity is linked directly to multiple comorbidities

Beyond glycemic control, GLP-1RAs deliver cardioprotective and renoprotective effects, reduce major cardiovascular events, and carry a low risk of hypoglycemia

Obesity is considered as a cosmetic disease or a lack of willpower

We tailor our solutions to their unique requirements

Clinicians have reported using GLP-1RAs to short-circuit addictions to gambling and sex

In most cases, yes